Navigation Links
GenVec Reports Fourth Quarter And 2012 Year-End Financial Results
Date:3/22/2013

s decreased 18% to $14.3 million in 2012 from $17.4 million in 2011.  In 2012 we experienced lower research and development costs than in the prior year due primarily to decreased manufacturing costs in the hearing and FMD programs, the closeout of the PACT trial, reduced personnel costs as a result of our reduction in force, reduced material costs for our funded programs, and reduced equipment purchases under our hearing and FMD programs.  These decreases were partially offset by increased outside costs for our other research programs as compared to 2011.

General and administrative expenses increased 17% to $9.1 million in 2012 from $7.8 million in 2011.  General and administrative expenses were higher in 2012 primarily due to personnel costs, which included approximately $1.3 million in non-recurring employment costs.

Fourth Quarter 2012 ResultsFor the fourth quarter ended December 31, 2012, GenVec reported a net loss of $3.2 million, or $0.24 per share, compared with a net loss of $2.5 million, or $0.19 per share, for the comparable prior year period.  The Company reported revenues of $1.5 million in the fourth quarter of 2012 compared to $3.4 million for the same period in 2011.  This decrease was primarily due to reduced revenue related to both our hearing loss and balance disorders program, $1.3 million, and FMD program, $0.2 million.  Reduced revenue in each case is due to a reduced work scope in the 2012 period as compared to the same period in 2011.  Research and development expenses decreased 21% in 2012 from $3.9 million in the fourth quarter of 2011 to $3.1 million in the fourth quarter of 2012 due mainly to reduced personnel and manufacturing costs.  General and administrative expenses in the fourth quarter of 2012 decreased 20% to $1.6 million from $2.0 million in the comparable period in 2011 primarily due to decreased personnel and recruiting costs, partially offset by higher professional costs.
'/>"/>

SOURCE GenVec, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. GenVec To Release First Quarter 2012 Financial Results And Conduct A Conference Call On May 10, 2012
2. GenVec Appoints Cynthia Collins as President and CEO
3. GenVec Reports Inducement Award
4. GenVec Announces Conditional Approval of FMD Vaccine for Cattle
5. GenVec to Release Second Quarter 2012 Financial Results and Conduct a Conference Call on August 9, 2012
6. GenVec Reports Second Quarter 2012 Financial Results
7. GenVec Reports Third Quarter 2012 Financial Results
8. GenVec to Present at 25th Annual ROTH Conference
9. GenVec To Release Fourth Quarter And Year-end 2012 Financial Results And Conduct A Conference Call On March 22, 2013
10. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
11. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... , Sept. 2, 2014  Volcano Corporation (Nasdaq: ... on improving patient and economic outcomes on a ... invasive coronary and peripheral visualization, physiology diagnostics and ... in the Morgan Stanley Healthcare conference on Tuesday, ... Scott Huennekens , president and chief executive officer, ...
(Date:9/2/2014)... , Sept. 2, 2014  Arena Pharmaceuticals, Inc. (NASDAQ: ... Food and Drug Administration (FDA) has granted orphan drug ... hypertension. "The FDA Office of Orphan ... from sponsors to identify and designate drug candidates that ... evaluation and development of such products," said Craig ...
(Date:9/2/2014)... Sept. 2, 2014  MEI Pharma, Inc. (Nasdaq: ... on the clinical development of novel therapies for ... in a randomized Phase II clinical trial of ... with azacitidine in patients with previously untreated intermediate-2 ... double-blind study enrolled a total of 108 patients ...
Breaking Medicine Technology:Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension 2Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension 3Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension 4MEI Pharma Completes Enrollment In Randomized Phase II Clinical Trial Of Pracinostat In Front Line Myelodysplastic Syndrome 2MEI Pharma Completes Enrollment In Randomized Phase II Clinical Trial Of Pracinostat In Front Line Myelodysplastic Syndrome 3MEI Pharma Completes Enrollment In Randomized Phase II Clinical Trial Of Pracinostat In Front Line Myelodysplastic Syndrome 4
... Oct. 6 According to Millennium Research Group ... intelligence, growth in the $2 billion US cardiac ... the expanded approval of Boston Scientific,s chronic resynchronization ... I and II patients. The New ...
... Oct. 6 e-MDs, an industry leader in ... (EHRs) and practice management (PM) solutions,  congratulates  the ... Family Medicine of Fort Collins, CO, for their ... of Excellence recipients.  The Healthcare Information and Management ...
Cached Medicine Technology:Positive Results From the MADIT-CRT Trial Support the Expanding Approval of Cardiac Resynchronization Therapy Defibrillators 2Positive Results From the MADIT-CRT Trial Support the Expanding Approval of Cardiac Resynchronization Therapy Defibrillators 3e-MDs Clients Win HIMSS Davies Awards of Excellence 2e-MDs Clients Win HIMSS Davies Awards of Excellence 3e-MDs Clients Win HIMSS Davies Awards of Excellence 4
(Date:9/2/2014)... believe that marijuana is not addictive, but a new ... able to obtain and consume cannabis legally for medical ... likely to perceive it as addictive or harmful," study ... Center for Addiction Medicine, said in a hospital news ... have significant consequences, and we know that among adolescents ...
(Date:9/2/2014)... PA (PRWEB) September 02, 2014 ... communications and education, is proud to announce the acquisition ... clinical resource center designed for healthcare professionals who integrate ... offers practitioners comprehensive access to:, , ... Dedicated topic centers for diabetes, oncology, renal ...
(Date:9/2/2014)... Mass. (PRWEB) September 02, 2014 Healthcare ... latest and most complete oncology guidelines available at the ... Health and the National Comprehensive Cancer Network® ... with other evidence and guidelines in the content available ... , NCCN, a not-for-profit alliance of 25 of ...
(Date:9/2/2014)... from cancer surgery may be influenced by more ... Family conflicts and other non-medical problems may raise ... study has found. Addressing such quality-of-life issues before ... recoveries and save health care dollars, the research ... patients, and found that patients with a poor ...
(Date:9/2/2014)... New research involving mice suggests that the key to ... medicine cabinet. In a report published in the ... that macrophages from the lungs of old mice had ... from young mice, but these changes were reversed by ... consequences on immune function," said Joanne Turner, Ph.D., a ...
Breaking Medicine News(10 mins):Health News:'Pot Addiction' May Be Real, Study Suggests 2Health News:HMP Communications Holdings, LLC, Acquires Nutrition411.com 2Health News:DynaMed™ to Utilize Information from the National Comprehensive Cancer Network® 2Health News:DynaMed™ to Utilize Information from the National Comprehensive Cancer Network® 3Health News:DynaMed™ to Utilize Information from the National Comprehensive Cancer Network® 4Health News:Family conflicts, other non-physical worries before cancer surgery raise patients' complication risk 2
... calls for specialized pediatric care, researchers say , ... to account for about 44 percent of the estimated ... earthquake -- information that could be used to guide ... the team at Children,s Hospital Los Angeles and the ...
... report using treatments, study finds, , THURSDAY, Jan. 28 ... adolescents in the United States use complementary or alternative ... researchers. , Most of these children have serious chronic ... effectiveness of the alternative remedies, especially when they are ...
... , PALM CITY, Fla. , ... Sheets: CTYX) is pleased to announce that it has secured ... U.S. Trademark #3,739,453 for the protection of the MedFlash name, ... Cl.: 9 designation in class 9 (U.S. CLS. 21, 23, ...
... Consumer survey results indicate ,having work done, not taboo ... Cosmetic surgery is everywhere these days: TV, magazines, the ... indeed more comfortable talking about cosmetic surgery than ever before. ... of Cosmetic Surgery, 71 percent of respondents think society is ...
... , , , , , ... Jan. 28 /PRNewswire-Asia-FirstCall/ -- Biostar,Pharmaceuticals, Inc. (OTC Bulletin ... and supplier of pharmaceutical,products and medical nutrients addressing a ... January 22, 2010 , its Board of Directors had,appointed ...
... ... today that it has been selected by Central Garden & Pet Company (NASDAQ:CENT) as ... ... -- SiteHawk, the leading MSDS and chemical data management company, announced today that it ...
Cached Medicine News:Health News:Haitian Children Need Specific Relief Efforts 2Health News:Kids' Use of Alternative Therapies Often Mimics Parents' 2Health News:Connectyx Granted U.S. Trademark for MedFlash(R) 2Health News:Connectyx Granted U.S. Trademark for MedFlash(R) 3Health News:Society More Open Than Ever About Cosmetic Surgery 2Health News:Biostar Pharmaceuticals, Inc. Announces Change of Auditor 2Health News:Biostar Pharmaceuticals, Inc. Announces Change of Auditor 3Health News:Central Garden & Pet Selects SiteHawk as Its MSDS Management Provider 2
... Insertion Through A 1.0mm Incision., ,Special Direct ... ... Comfortable Approach., ,Recessed Jaws For Improved Sub-Incisional ... Of Jaws During Sterilization., ,Reusable, Autoclaveable, Guaranteed ...
The New Easy-To-Use Disposable Diamond Knife Cleaning System Can Remove Even Baked-On Debris In Seconds. It Is Much More Effective Than Steam Or Blocks Of Styrofoam, Much Safer For Employees As Wel...
... Corneal Gauges Allowing The Exact,Outer Diameter Measurement ... With 0.25mm ,Increments.,Easy And Quick To Use, ... And Place Over A Cornea For Confirmation ... The USA, ...
... Gauge Measures 360 Degrees & Can Be Set ... Cornea. 7mm Inner Diameter & 14mm Outer Diameter ... Astigmatism Gauge That Can Be Set For AKs, ... Around The Globe., ,Marks Single Or Paired AKs, ...
Medicine Products: